Genpact (G) Stock Price
Genpact Price
Revenue has compounded at 11.8% per year over the past 19 years to 5.08 B USD. Earnings per share have grown at 6.2% per year over the last 19 years. Genpact's net margin stands at 10.9%, up from 9.2% several years earlier. Genpact currently offers a dividend yield of about 2.01%. The payout ratio is around 22% of earnings. Analysts set a median price target of 53.55 USD, implying 58.2% above the current price. Of 20 analysts, 11 rate the stock a buy — an overall Buy consensus. The stock trades about 23% above its 52-week low.
Genpact stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Genpact over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Genpact stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Genpact's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Genpact Price |
|---|---|
| 8/14/2026 | 33.86 USD |
| 8/13/2026 | 34.37 USD |
| 8/12/2026 | 33.95 USD |
| 8/11/2026 | 33.96 USD |
| 8/10/2026 | 34.40 USD |
| 8/7/2026 | 34.29 USD |
| 8/6/2026 | 36.16 USD |
| 8/5/2026 | 35.20 USD |
| 8/4/2026 | 35.10 USD |
| 8/3/2026 | 35.16 USD |
| 7/31/2026 | 35.17 USD |
| 7/30/2026 | 35.33 USD |
| 7/29/2026 | 36.64 USD |
| 7/27/2026 | 32.39 USD |
| 7/23/2026 | 30.37 USD |
| 7/22/2026 | 30.01 USD |
| 7/21/2026 | 30.18 USD |
| 7/20/2026 | 30.64 USD |
| 7/17/2026 | 30.89 USD |
| 7/16/2026 | 31.22 USD |
| 7/15/2026 | 30.07 USD |
| 7/14/2026 | 29.52 USD |
| 7/13/2026 | 30.44 USD |
| 7/10/2026 | 29.37 USD |
| 7/9/2026 | 29.64 USD |
| 7/8/2026 | 29.59 USD |
| 7/7/2026 | 29.74 USD |
| 7/6/2026 | 29.02 USD |
| 7/2/2026 | 29.10 USD |
| 7/1/2026 | 28.26 USD |
| 6/30/2026 | 27.50 USD |
| 6/29/2026 | 27.99 USD |
| 6/26/2026 | 28.53 USD |
| 6/25/2026 | 27.67 USD |
| 6/24/2026 | 28.53 USD |
| 6/23/2026 | 28.28 USD |
| 6/22/2026 | 28.11 USD |
| 6/18/2026 | 28.25 USD |
| 6/17/2026 | 30.31 USD |
| 6/16/2026 | 31.32 USD |
| 6/15/2026 | 31.00 USD |
| 6/12/2026 | 32.06 USD |
| 6/11/2026 | 31.89 USD |
| 6/10/2026 | 32.19 USD |
| 6/5/2026 | 32.62 USD |
| 6/4/2026 | 32.86 USD |
| 6/3/2026 | 32.30 USD |
| 6/2/2026 | 32.84 USD |
| 6/1/2026 | 34.45 USD |
| 5/29/2026 | 32.95 USD |
| 5/28/2026 | 32.42 USD |
| 5/27/2026 | 31.58 USD |
| 5/26/2026 | 31.19 USD |
| 5/22/2026 | 31.91 USD |
| 5/21/2026 | 32.00 USD |
| 5/20/2026 | 32.12 USD |
| 5/14/2026 | 28.94 USD |
| 5/13/2026 | 29.44 USD |
| 5/4/2026 | 34.14 USD |
| 5/1/2026 | 34.33 USD |
| 4/30/2026 | 34.75 USD |
| 4/29/2026 | 33.88 USD |
| 4/28/2026 | 33.95 USD |
| 4/27/2026 | 33.83 USD |
| 4/24/2026 | 34.32 USD |
| 4/23/2026 | 34.50 USD |
| 4/22/2026 | 36.22 USD |
| 4/21/2026 | 37.03 USD |
| 4/20/2026 | 36.64 USD |
| 4/17/2026 | 36.93 USD |
| 4/16/2026 | 36.63 USD |
| 4/15/2026 | 36.24 USD |
| 4/14/2026 | 35.50 USD |
| 4/13/2026 | 35.54 USD |
| 4/10/2026 | 34.18 USD |
| 4/9/2026 | 35.54 USD |
| 4/8/2026 | 36.93 USD |
| 4/7/2026 | 37.49 USD |
| 4/6/2026 | 37.60 USD |
| 4/2/2026 | 37.84 USD |
| 4/1/2026 | 37.23 USD |
| 3/31/2026 | 37.25 USD |
| 3/30/2026 | 37.45 USD |
| 3/27/2026 | 36.60 USD |
| 3/26/2026 | 37.41 USD |
| 3/25/2026 | 37.66 USD |
| 3/24/2026 | 37.82 USD |
| 3/23/2026 | 38.71 USD |
| 3/20/2026 | 38.70 USD |
| 3/19/2026 | 38.31 USD |
| 3/18/2026 | 38.31 USD |
| 3/17/2026 | 38.34 USD |
| 3/16/2026 | 38.28 USD |
| 3/13/2026 | 38.30 USD |
| 3/12/2026 | 38.15 USD |
| 3/11/2026 | 38.75 USD |
| 3/10/2026 | 38.93 USD |
| 3/9/2026 | 40.86 USD |
| 3/6/2026 | 41.70 USD |
| 3/5/2026 | 41.68 USD |
| 3/4/2026 | 40.78 USD |
| 3/3/2026 | 40.36 USD |
| 3/2/2026 | 40.21 USD |
| 2/27/2026 | 39.72 USD |
| 2/26/2026 | 38.75 USD |
| 2/25/2026 | 37.81 USD |
| 2/24/2026 | 37.94 USD |
| 2/23/2026 | 37.54 USD |
| 2/20/2026 | 38.93 USD |
| 2/19/2026 | 38.86 USD |
| 2/18/2026 | 39.18 USD |
| 2/17/2026 | 37.73 USD |
| 2/13/2026 | 37.36 USD |
| 2/12/2026 | 36.31 USD |
| 2/11/2026 | 37.18 USD |
| 2/10/2026 | 39.14 USD |
| 2/9/2026 | 39.49 USD |
| 2/6/2026 | 40.39 USD |
| 2/5/2026 | 38.51 USD |
| 2/4/2026 | 38.34 USD |
| 2/3/2026 | 38.97 USD |
| 2/2/2026 | 44.13 USD |
| 1/30/2026 | 44.10 USD |
| 1/29/2026 | 44.61 USD |
| 1/28/2026 | 44.78 USD |
| 1/27/2026 | 45.27 USD |
| 1/26/2026 | 45.48 USD |
| 1/23/2026 | 45.80 USD |
| 1/22/2026 | 46.19 USD |
| 1/21/2026 | 45.73 USD |
| 1/20/2026 | 44.77 USD |
| 1/16/2026 | 45.91 USD |
| 1/15/2026 | 46.22 USD |
| 1/14/2026 | 47.44 USD |
| 1/13/2026 | 46.52 USD |
| 1/12/2026 | 47.13 USD |
| 1/9/2026 | 48.24 USD |
| 1/8/2026 | 47.62 USD |
| 1/7/2026 | 47.40 USD |
| 1/6/2026 | 47.35 USD |
| 1/5/2026 | 46.60 USD |
| 1/2/2026 | 45.91 USD |
| 12/31/2025 | 46.78 USD |
| 12/30/2025 | 47.18 USD |
| 12/29/2025 | 47.89 USD |
| 12/26/2025 | 48.05 USD |
| 12/24/2025 | 48.09 USD |
| 12/23/2025 | 48.13 USD |
| 12/22/2025 | 48.50 USD |
| 12/19/2025 | 47.91 USD |
| 12/18/2025 | 47.73 USD |
| 12/17/2025 | 47.95 USD |
| 12/16/2025 | 47.77 USD |
| 12/15/2025 | 47.35 USD |
| 12/12/2025 | 47.79 USD |
| 12/11/2025 | 47.36 USD |
| 12/10/2025 | 46.36 USD |
| 12/9/2025 | 45.61 USD |
| 12/8/2025 | 46.22 USD |
| 12/5/2025 | 46.37 USD |
| 12/4/2025 | 46.01 USD |
| 12/3/2025 | 45.31 USD |
| 12/2/2025 | 44.06 USD |
| 12/1/2025 | 44.19 USD |
| 11/28/2025 | 44.06 USD |
| 11/26/2025 | 44.21 USD |
| 11/25/2025 | 44.64 USD |
| 11/24/2025 | 44.08 USD |
| 11/21/2025 | 44.36 USD |
| 11/20/2025 | 43.73 USD |
| 11/19/2025 | 43.92 USD |
| 11/18/2025 | 43.80 USD |
| 11/17/2025 | 43.74 USD |
| 11/14/2025 | 44.89 USD |
| 11/13/2025 | 45.05 USD |
| 11/12/2025 | 45.54 USD |
| 11/11/2025 | 44.89 USD |
| 11/10/2025 | 44.27 USD |
| 11/7/2025 | 44.49 USD |
| 11/6/2025 | 41.45 USD |
| 11/5/2025 | 38.82 USD |
| 11/4/2025 | 38.43 USD |
| 11/3/2025 | 38.12 USD |
| 10/31/2025 | 38.15 USD |
| 10/30/2025 | 38.12 USD |
| 10/29/2025 | 37.89 USD |
| 10/28/2025 | 39.21 USD |
| 10/27/2025 | 39.51 USD |
| 10/24/2025 | 39.78 USD |
| 10/23/2025 | 39.78 USD |
| 10/22/2025 | 39.78 USD |
| 10/21/2025 | 40.29 USD |
| 10/20/2025 | 39.86 USD |
| 10/17/2025 | 39.51 USD |
| 10/16/2025 | 38.95 USD |
| 10/15/2025 | 39.42 USD |
| 10/14/2025 | 39.86 USD |
| 10/13/2025 | 39.52 USD |
| 10/10/2025 | 39.31 USD |
| 10/9/2025 | 40.18 USD |
| 10/8/2025 | 40.67 USD |
| 10/7/2025 | 40.70 USD |
| 10/6/2025 | 41.11 USD |
| 10/3/2025 | 41.35 USD |
| 10/2/2025 | 41.40 USD |
| 10/1/2025 | 41.84 USD |
| 9/30/2025 | 41.89 USD |
| 9/29/2025 | 42.17 USD |
| 9/28/2025 | 42.17 USD |
| 9/25/2025 | 42.21 USD |
| 9/24/2025 | 41.79 USD |
| 9/23/2025 | 41.06 USD |
| 9/22/2025 | 41.15 USD |
| 9/19/2025 | 41.13 USD |
| 9/18/2025 | 41.30 USD |
| 9/17/2025 | 41.77 USD |
| 9/16/2025 | 41.33 USD |
| 9/15/2025 | 42.11 USD |
| 9/12/2025 | 42.56 USD |
| 9/11/2025 | 43.33 USD |
| 9/10/2025 | 43.00 USD |
| 9/9/2025 | 43.69 USD |
| 9/8/2025 | 44.27 USD |
| 9/5/2025 | 45.02 USD |
| 9/4/2025 | 44.97 USD |
| 9/3/2025 | 45.20 USD |
| 9/2/2025 | 44.89 USD |
| 8/29/2025 | 45.13 USD |
| 8/28/2025 | 44.97 USD |
| 8/27/2025 | 45.41 USD |
| 8/26/2025 | 45.10 USD |
| 8/25/2025 | 45.45 USD |
| 8/22/2025 | 45.21 USD |
| 8/21/2025 | 44.52 USD |
| 8/20/2025 | 44.04 USD |
| 8/19/2025 | 44.79 USD |
Genpact Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Genpact Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEB USD |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEB USD |
| EBITM USD |
| EBIT MARGIN% |
| NET INCOMEM USD |
| NET INCOME GROWTH% |
| DIVIDENDDIV.USD |
| DIVIDEND GROWTHDIV. GROWTH% |
| SHARESM |
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026e | 2027e | 2028e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.13 | 2.28 | 2.46 | 2.57 | 2.74 | 3.00 | 3.52 | 3.71 | 4.02 | 4.37 | 4.48 | 4.77 | 5.08 | 5.44 | 5.82 | 6.32 |
| 12.15 | 6.89 | 7.99 | 4.43 | 6.46 | 9.65 | 17.33 | 5.37 | 8.44 | 8.68 | 2.40 | 6.50 | 6.54 | 7.03 | 7.12 | 8.55 |
| 38.09 | 39.53 | 39.29 | 39.53 | 38.56 | 35.97 | 34.80 | 34.81 | 35.58 | 35.14 | 35.08 | 35.45 | 35.56 | 35.56 | 35.56 | 35.56 |
| 0.81 | 0.90 | 0.97 | 1.02 | 1.06 | 1.08 | 1.23 | 1.29 | 1.43 | 1.54 | 1.57 | 1.69 | 1.81 | 1.93 | 2.07 | 2.25 |
| 309.00 | 294.00 | 334.00 | 341.00 | 331.00 | 385.00 | 429.00 | 438.00 | 508.00 | 502.00 | 630.00 | 702.00 | 760.00 | 778.00 | 835.00 | 904.00 |
| 14.49 | 12.90 | 13.57 | 13.27 | 12.10 | 12.83 | 12.19 | 11.81 | 12.63 | 11.48 | 14.08 | 14.73 | 14.96 | 14.31 | 14.34 | 14.30 |
| 235.00 | 192.00 | 239.00 | 267.00 | 260.00 | 281.00 | 304.00 | 308.00 | 369.00 | 353.00 | 631.00 | 513.00 | 552.00 | 727.00 | 796.00 | 905.00 |
| 27.72 | -18.30 | 24.48 | 11.72 | -2.62 | 8.08 | 8.19 | 1.32 | 19.81 | -4.34 | 78.75 | -18.70 | 7.60 | 31.70 | 9.49 | 13.69 |
| – | – | – | – | 0.24 | 0.30 | 0.34 | 0.39 | 0.43 | 0.50 | 0.55 | 0.61 | 0.68 | 0.75 | 0.84 | 0.94 |
| – | – | – | – | – | 25.00 | 13.33 | 14.71 | 10.26 | 16.28 | 10.00 | 10.91 | 11.48 | 10.29 | 12.00 | 11.90 |
| 230.06 | 216.47 | 215.68 | 203.43 | 196.86 | 193.15 | 196.59 | 194.82 | 193.19 | 187.53 | 183.35 | 180.44 | 174.99 | 174.99 | 174.99 | 174.99 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Genpact generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Genpact retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Genpact's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Genpact has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Genpact's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Genpact stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Genpact Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Genpact business model & stock analysis
Genpact SWOT Analysis
Strengths
Genpact Ltd possesses several strengths that contribute to its competitive advantage and success in the market:
- Strong market position and brand recognition.
- Extensive industry knowledge and expertise.
- Global presence and diversified customer base.
- Robust technology infrastructure.
- Wide range of services and solutions offered.
- Strong relationships with strategic partners.
Despite its strengths, Genpact Ltd also faces certain weaknesses that could hinder its growth and performance:
- Dependence on key clients for a significant portion of revenue.
- Vulnerability to economic fluctuations and market uncertainties.
- Integration challenges resulting from mergers and acquisitions.
- Limited diversification in terms of industry sectors served.
- Highly competitive market landscape.
Genpact Ltd can leverage the following opportunities to further expand and enhance its business operations:
- Increased adoption of digital technologies and automation.
- Emerging markets with untapped potential for outsourcing services.
- Growing demand for analytics and data-driven decision-making.
- Expansion into new industry sectors and service lines.
- Strategic partnerships and collaborations.
Genpact Ltd should be aware of the following threats that might affect its business operations and market position:
- Intense competition from both established and emerging players.
- Regulatory changes and compliance requirements.
- Rapid technological advancements requiring continuous innovation.
- Economic downturns impacting client spending and investment decisions.
- Challenges related to talent acquisition and retention.
Weaknesses
Despite its strengths, Genpact Ltd also faces certain weaknesses that could hinder its growth and performance:
- Dependence on key clients for a significant portion of revenue.
- Vulnerability to economic fluctuations and market uncertainties.
- Integration challenges resulting from mergers and acquisitions.
- Limited diversification in terms of industry sectors served.
- Highly competitive market landscape.
Genpact Ltd can leverage the following opportunities to further expand and enhance its business operations:
- Increased adoption of digital technologies and automation.
- Emerging markets with untapped potential for outsourcing services.
- Growing demand for analytics and data-driven decision-making.
- Expansion into new industry sectors and service lines.
- Strategic partnerships and collaborations.
Genpact Ltd should be aware of the following threats that might affect its business operations and market position:
- Intense competition from both established and emerging players.
- Regulatory changes and compliance requirements.
- Rapid technological advancements requiring continuous innovation.
- Economic downturns impacting client spending and investment decisions.
- Challenges related to talent acquisition and retention.
Opportunities
Genpact Ltd can leverage the following opportunities to further expand and enhance its business operations:
- Increased adoption of digital technologies and automation.
- Emerging markets with untapped potential for outsourcing services.
- Growing demand for analytics and data-driven decision-making.
- Expansion into new industry sectors and service lines.
- Strategic partnerships and collaborations.
Genpact Ltd should be aware of the following threats that might affect its business operations and market position:
- Intense competition from both established and emerging players.
- Regulatory changes and compliance requirements.
- Rapid technological advancements requiring continuous innovation.
- Economic downturns impacting client spending and investment decisions.
- Challenges related to talent acquisition and retention.
Threats
Genpact Ltd should be aware of the following threats that might affect its business operations and market position:
- Intense competition from both established and emerging players.
- Regulatory changes and compliance requirements.
- Rapid technological advancements requiring continuous innovation.
- Economic downturns impacting client spending and investment decisions.
- Challenges related to talent acquisition and retention.
Genpact Employees
3 Years
5 Years
10 Years
25 Years
Max
Details
Genpact Segments
Genpact Revenue by Segment (1/2)
3 Years
5 Years
10 Years
25 Years
Max
Details
Genpact Revenue by Segment (2/2)
3 Years
5 Years
10 Years
Max
Details
Genpact Revenue by Region
3 Years
5 Years
10 Years
Max
Details
Genpact Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
Genpact historical P/E ratio, EBIT multiple, and P/S ratio
Genpact annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Genpact shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Genpact Dividend History
11 years of dividend payments · 8 consecutive increases
Genpact dividend history and estimates
Max
Details
Genpact dividend payout ratio
3 Years
5 Years
10 Years
25 Years
Max
Details
Current Genpact forecasts and price targets in August 2026
Analyst Price Targets 2026Genpact Analyst Rating Actions
| Date | Firm | Action | Rating | Reliability |
|---|---|---|---|---|
| 7/9/2026 | Maintained | Buy | 60 | |
| 7/7/2026 | Maintained | Neutral | 56 | |
| 5/11/2026 | Maintained | Neutral | 31 | |
| 5/11/2026 | Maintained | Neutral | 38 | |
| 5/11/2026 | Maintained | Neutral | 56 | |
| 5/8/2026 | Maintained | Buy | 70 | |
| 5/5/2026 | Maintained | Neutral | – | |
| 2/10/2026 | Maintained | Neutral | 31 | |
| 2/6/2026 | Maintained | Buy | 70 | |
| 8/20/2025 | Maintained | Neutral | 60 |
Eulerpool Reliability Score (0–100): measures how often a firm’s bullish or bearish calls were directionally correct three months later, blended with the average return following its calls. Every rating we record is stored permanently and scores update continuously; firms with fewer than 3 measured calls are not scored yet.
Genpact Earnings Estimates & Surprises
| Date | EPS estimate | EPS Actual | Revenue Estimate | Price reaction | Quarterly report |
|---|---|---|---|---|---|
| 8/6/2026 | 0.98USD | - | 1.36 BUSD | - | 2026 Q2 |
| 5/7/2026 | 0.94USD | - | 1.32 BUSD | - | 2026 Q1 |
| 2/5/2026 | 0.95USD | - | 1.33 BUSD | - | 2025 Q4 |
| 5/8/2024 | 0.73USD | - | 1.14 BUSD | - | 2024 Q1 |
| 2/7/2024 | 0.75USD | - | 1.14 BUSD | - | 2023 Q4 |
| 11/7/2023 | 0.81USD | - | 1.22 BUSD | - | 2023 Q3 |
| 8/2/2023 | 0.75USD | - | 1.18 BUSD | - | 2023 Q2 |
| 5/3/2023 | 0.68USD | - | 1.13 BUSD | - | 2023 Q1 |
| 2/9/2023 | 0.70USD | - | 1.10 BUSD | - | 2022 Q4 |
| 11/9/2022 | 0.70USD | - | 1.10 BUSD | - | 2022 Q3 |
EESG©
Eulerpool ESG Scorecard© for the Genpact stock
EEnvironment
20
Environment
SSocial
20
Social
GGovernance (Corporate Governance)
4
Governance (Corporate Governance)
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
Genpact shareholder structure
| % | Name |
|---|---|
11.25937% | |
8.50977% | |
7.75701% | |
6.38486% | |
4.89286% | |
4.22195% |
Genpact Beneficial Ownership Filings (SEC 13D/G)
| Stake | Holder | Filing |
|---|---|---|
15.10% | SEC ↗ | |
14.09% | SEC ↗ | |
12.06% | SEC ↗ | |
11.40% | SEC ↗ | |
11.24% | SEC ↗ | |
9.00% | SEC ↗ | |
8.81% | SEC ↗ | |
6.94% | SEC ↗ | |
6.64% | SEC ↗ | |
6.37% | SEC ↗ |
Genpact Executives and Management Board
19 members · avg. age 58 · 32 % women
Mr. Balkrishan Kalra (55)
President, Chief Executive Officer, Director · since 2008
10.88 M USD
Management
Mr. Michael Weiner (53)
Chief Financial Officer, Senior Vice President
Ms. Riju Vashisht (57)
Senior Vice President, Chief Growth Officer and Global Business Leader, Enterprise Services and Partnerships & Alliances
Mr. Piyush Mehta (56)
Senior Vice President, Chief Human Resources Officer and Country Manager, India
Mr. Anil Nanduru (50)
Senior Vice President, Global Business Leader, High Tech & Manufacturing and Consumer & Healthcare
Mr. Anthony Radesca (56)
Senior Vice President, Chief Accounting Officer
Ms. Heather White (52)
Senior Vice President, Chief Legal Officer, Corporate Secretary
Board of Directors
Mr. James Madden (63)
Non-Executive Independent Chairman of the Board
Ms. Laura Conigliaro (79)
Independent Director
Ms. Carol Lindstrom (72)
Independent Director
Mr. Mark Verdi (58)
Independent Director
Ms. Tamara Franklin (58)
Independent Director
Ms. Cecelia Morken (67)
Independent Director
Frequently asked questions about Genpact
The business model of Genpact Ltd is focused on providing digital transformation services to various industries. As a global professional services firm, Genpact leverages its expertise in data analytics, technology, and process optimization to help businesses streamline operations, enhance customer experiences, and drive growth. By combining its deep domain knowledge with advanced technologies like artificial intelligence and automation, Genpact enables organizations to improve efficiency, reduce costs, and stay competitive in today's rapidly evolving market. Genpact's business model revolves around delivering innovative solutions and strategic insights that empower its clients to stay ahead in the digital age.
Genpact Ltd is primarily active in the industries of business process outsourcing (BPO), information technology services, and digital transformation.
The main competitors of Genpact Ltd in the market are Accenture, Cognizant, and Infosys.
Genpact Ltd is a global professional services firm that provides digital transformation, consulting, and operational services. Established in 1997 as a business unit of General Electric, Genpact has since grown into a standalone company with a strong presence in over 30 countries. The company specializes in helping clients across industries streamline their operations and improve their business outcomes. With a focus on digital solutions and advanced analytics, Genpact assists organizations in enhancing their customer experiences, optimizing their supply chains, and driving innovation. As a leader in its field, Genpact continues to deliver impactful results and drive global business success.
Genpact Ltd, a prominent global professional services firm, has reached several significant milestones since its inception. Over the years, the company has established a strong reputation for delivering high-quality services to clients across various industries. Genpact became a publicly traded company in 2007, marking a major achievement in its corporate journey. Additionally, the firm has expanded its global presence, leveraging its expertise in fields such as digital transformation, analytics, and artificial intelligence. Genpact has consistently demonstrated its commitment to innovation, earning recognition as a leader in various industry assessments. Through its unwavering dedication to excellence, Genpact Ltd has solidified its position as a trusted partner for businesses worldwide.
Genpact Ltd is primarily present in various countries and regions worldwide. The company has a strong global presence and operates in more than 30 countries, including the United States, India, China, the United Kingdom, Australia, and many more. With its extensive network, Genpact serves clients from diverse industries in various regions, providing them with transformative digital solutions and services.
Genpact Ltd is a global professional services firm that focuses on digitally-powered business process management and services. The company's corporate philosophy revolves around four core values: integrity, drive, intelligence, and passion. Genpact believes in maintaining the highest standards of ethical conduct and putting clients' interests first. With a relentless drive for excellence, Genpact leverages technology and analytics to drive innovation and deliver transformative outcomes for its clients. By fostering a culture of continuous learning and collaboration, Genpact promotes intelligence and empowers its employees to solve complex business challenges. Ultimately, Genpact's philosophy aims to create sustainable value and make a positive impact on its clients, employees, and communities.
Analysts currently set an average price target of 52.44 USD for the Genpact stock (median: 53.55 USD), implying +50.5 % versus the latest price. The consensus is based on 20 analyst ratings.
20 analysts currently rate the Genpact stock: 11 recommend buying, 9 holding and 0 selling. For 2026, analysts expect Genpact to generate revenue of 5.44 B USD and earnings per share of 4.16 USD.
Converted at the current exchange rate, the Genpact share trades at 29.25 EUR (33.86 USD).
The Genpact share (G) is listed on 4 stock exchanges, including: NYSE (G), Frankfurt (35G.F), München (35G.MU), Düsseldorf (35G.DU).
The company Genpact Ltd is a global service company specializing in business process management and technology solutions. It was founded in 1997 and is headquartered in New York City. Genpact offers a wide range of services aimed at improving the efficiency, quality, and agility of business processes. The company has a strong presence in various industries such as banking, insurance, healthcare, retail, and telecommunications. One of Genpact's key divisions is Finance & Accounting (F&A). Here, the company offers services such as accounting, invoicing, payment processing, and financial planning & analysis (FP&A). Genpact's F&A division supports companies in improving the efficiency and accuracy of financial processes, compliance with regulations, and achieving cost savings. Another important division of Genpact is Transformation Services. Here, the company works closely with its clients to optimize their business processes from analysis and planning to the implementation of improvement measures. Genpact provides its clients with a comprehensive range of services, from process optimization to change management to the introduction of technology and automation solutions. In addition to the mentioned divisions, Genpact also offers services in the areas of Customer Experience Management (CEM), Supply Chain Management (SCM), and Analytics & Research. In the CEM field, Genpact supports companies in improving customer satisfaction and loyalty by using data-driven insights to analyze customer feedback and derive measures to improve the customer experience. In the SCM field, Genpact offers solutions for optimizing the supply chain to optimize flows of goods, inventory, and delivery times, thereby increasing customer satisfaction and reducing costs. In the Analytics & Research field, Genpact offers its clients advanced analytics solutions to help make data-driven decisions and gain a competitive advantage. In addition to its various divisions, Genpact also offers products such as its Lean Digital Suite. This suite includes various tools and technologies aimed at simplifying and automating business processes. The Lean Digital Suite is designed to improve the speed, efficiency, and quality of business processes while reducing costs. Genpact's business model is based on supporting companies in optimizing their business processes and increasing efficiency to gain a competitive advantage. Genpact utilizes advanced technologies such as automation, data analytics, and artificial intelligence to help its clients streamline and optimize their business processes.
The expected revenue of Genpact is 5.44 B USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Genpact is 727.84 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Genpact is currently 8.14. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Genpact stock.
The price-to-sales ratio (P/S) of Genpact is currently 1.09. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Genpact stock.
The Eulerpool Quality Score for Genpact is 8/10.
The ISIN of Genpact is BMG3922B1072. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Genpact is A0MXL7. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Genpact is G. The ticker symbol is used to trade Genpact shares on the stock exchange.
Over the past 12 months, Genpact paid a dividend of 0.68 USD . This corresponds to a dividend yield of about 2.01 %. For the coming 12 months, Genpact is expected to pay a dividend of 0.84 USD.
The current dividend yield of Genpact is 2.01 %.
Genpact pays a dividend, distributed in the months of , , , .
Genpact paid dividends every year for the past 9 years.
For the upcoming 12 months, dividends amounting to 0.84 USD are expected. This corresponds to a dividend yield of 2.48 %.
Genpact is assigned to the 'Information technology' sector.
To receive the latest dividend of Genpact from amounting to 0.19 USD, you needed to have the stock in your portfolio before the ex-date on .
The last dividend was paid out on .
In the year 2025, Genpact distributed 0.61 USD as dividends.
The dividends of Genpact are distributed in USD.
Genpact stock
Genpact Peer Group
Genpact Ticker
Genpact FIGI
All fundamentals and in-depth analysis of Genpact
Our stock analysis for Genpact stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Genpact. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.